UB Paderborn / Katalog / Suche / in CDI

Robust patient-derived xenografts of MDS/MPN overlap syndromes capture the unique characteristics of CMML and JMML

Blood, 2017-07, Vol.130 (4), p.397-407

2017

Volltextzugriff (PDF)

Desensitization using pegaspargase in the era of commercially available Erwinia: A single‐institution report on efficacy, cost, and resource utilization

Pediatric blood & cancer, 2024-04, Vol.71 (4), p.e30891-n/a

2024

Volltextzugriff (PDF)

P3‐330: Towards a Dementia Simulation: Stepping into the Mind of a Long‐Term Care Resident Living with Dementia

Alzheimer's & dementia, 2016-07, Vol.12 (7S_Part_20), p.P973-P973

2016

Volltextzugriff (PDF)

TOWARDS A DEMENTIA SIMULATION: STEPPING INTO THE MIND OF A LONG-TERM CARE RESIDENT LIVING WITH DEMENTIA

Alzheimer's & dementia, 2016-07, Vol.12 (7), p.P973-P973

2016

Volltextzugriff (PDF)

Knowledge translation: An interprofessional approach to integrating a pain consult team within an acute care unit

Journal of interprofessional care, 2016-11, Vol.30 (6), p.816-818

2016

Volltextzugriff (PDF)

Knowledge translation: An interprofessional approach to integrating a pain consult team within an acute care unit

Journal of Interprofessional Care, 2016, Vol.30 (6), p.816-818

2016

Volltextzugriff (PDF)

Distinct Early Serological Signatures Track with SARS-CoV-2 Survival

Immunity (Cambridge, Mass.), 2020-09, Vol.53 (3), p.524-532.e4

2020

Volltextzugriff (PDF)

Combinatorial Auctions with Interdependent Valuations: SOS to the Rescue

Mathematics of operations research, 2024-05, Vol.49 (2), p.653-674

2024

Volltextzugriff (PDF)

A Metabolically Optimized, Noncytotoxic Low-Dose Weekly Decitabine/Venetoclax in MDS and AML

Clinical cancer research, 2023-08, Vol.29 (15), p.2774-2780

2023

Volltextzugriff (PDF)

Constant Approximation for Private Interdependent Valuations

2023 IEEE 64th Annual Symposium on Foundations of Computer Science (FOCS), 2023, p.148-163

2023

Volltextzugriff (PDF)

Medical Care Delivery in U.S. Nursing Homes: Current and Future Practice

The Gerontologist, 2021-06, Vol.61 (4), p.595-604

2021

Volltextzugriff (PDF)

Low-Dose Weekly Decitabine and Venetoclax in TP53-Mutated Myeloid Malignancies

Blood, 2021-11, Vol.138 (Supplement 1), p.4428-4428

2021

Volltextzugriff (PDF)

Effect of upfront HSCT on patients with T-cell acute lymphoblastic leukemia/lymphoblastic lymphoma at high risk of relapse: Single center retrospective observational study on minority rich population

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e19014-e19014

2023

Volltextzugriff (PDF)

A Non-Cytotoxic Regimen Using a Weekly Low Dose Decitabine and Venetoclax for MDS and AML in a Real World Cohort

Blood, 2022-11, Vol.140 (Supplement 1), p.6218-6219

2022

Volltextzugriff (PDF)

Low-dose weekly decitabine and venetoclax in TP53 -mutated myeloid malignancies

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e19005-e19005

2022

Volltextzugriff (PDF)

Association of ethnicity with overall survival in patients with T-cell acute lymphoblastic leukemia/lymphoblastic lymphoma

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e18557-e18557

2023

Volltextzugriff (PDF)

Efficacy and safety of CAR-T cell therapy in minorities

Bone marrow transplantation (Basingstoke), 2022-07, Vol.57 (7), p.1187-1190

2022

Volltextzugriff (PDF)

Venetoclax Plus Intensive Chemotherapy in AML and Advanced MDS: Assessment of Leukemia Stem Cell Eradication By High-Resolution MRD Assay

Blood, 2022-11, Vol.140 (Supplement 1), p.3360-3361

2022

Volltextzugriff (PDF)

P524: PHARMACODYNAMICALLY DEFINED METRONOMIC DOSING OF DECITABINE AND VENETOCLAX IN ACUTE MYELOID LEUKEMIA

HemaSphere, 2023-08, Vol.7 (S3), p.e90768e2-n/a

2023

Volltextzugriff (PDF)

P488: SAFETY AND EFFICACY OF VENETOCLAX PLUS “7 + 3” CHEMOTHERAPY IN NEWLY DIAGNOSED AML

HemaSphere, 2023-08, Vol.7 (S3), p.e46119b8-n/a

2023

Volltextzugriff (PDF)

Socio-demographic determinants of myelofibrosis outcomes in an underserved center and the SEER national database

Annals of hematology, 2024-07, Vol.103 (9), p.3543-3551

2024

Volltextzugriff (PDF)

Poster: AML-351 Low-Dose Weekly Decitabine and Venetoclax in TP53-Mutated Myeloid Malignancies

Clinical lymphoma, myeloma and leukemia, 2022-10, Vol.22, p.S134

2022

Volltextzugriff (PDF)

AML-351 Low-Dose Weekly Decitabine and Venetoclax in Myeloid Malignancies

Clinical lymphoma, myeloma and leukemia, 2022-10, Vol.22, p.S241

2022

Volltextzugriff (PDF)

ACR Appropriateness Criteria® Acute Pelvic Pain in the Reproductive Age Group: 2023 Update

Journal of the American College of Radiology, 2024-06, Vol.21 (6), p.S3-S20

2024

Volltextzugriff (PDF)

ALL-040 Hispanic Patients With T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma Had Worse Overall Survival in a Minority Predominant Cohort

Clinical lymphoma, myeloma and leukemia, 2023-09, Vol.23, p.S238-S239

2023

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Robust patient-derived xenografts of MDS/MPN overlap syndromes capture the unique characteristics of CMML and JMML

Desensitization using pegaspargase in the era of commercially available Erwinia: A single‐institution report on efficacy, cost, and resource utilization

P3‐330: Towards a Dementia Simulation: Stepping into the Mind of a Long‐Term Care Resident Living with Dementia

TOWARDS A DEMENTIA SIMULATION: STEPPING INTO THE MIND OF A LONG-TERM CARE RESIDENT LIVING WITH DEMENTIA

Knowledge translation: An interprofessional approach to integrating a pain consult team within an acute care unit

Knowledge translation: An interprofessional approach to integrating a pain consult team within an acute care unit

Distinct Early Serological Signatures Track with SARS-CoV-2 Survival

Combinatorial Auctions with Interdependent Valuations: SOS to the Rescue

A Metabolically Optimized, Noncytotoxic Low-Dose Weekly Decitabine/Venetoclax in MDS and AML

Constant Approximation for Private Interdependent Valuations

Medical Care Delivery in U.S. Nursing Homes: Current and Future Practice

Low-Dose Weekly Decitabine and Venetoclax in TP53-Mutated Myeloid Malignancies

Effect of upfront HSCT on patients with T-cell acute lymphoblastic leukemia/lymphoblastic lymphoma at high risk of relapse: Single center retrospective observational study on minority rich population

A Non-Cytotoxic Regimen Using a Weekly Low Dose Decitabine and Venetoclax for MDS and AML in a Real World Cohort

Low-dose weekly decitabine and venetoclax in TP53 -mutated myeloid malignancies

Association of ethnicity with overall survival in patients with T-cell acute lymphoblastic leukemia/lymphoblastic lymphoma

Efficacy and safety of CAR-T cell therapy in minorities

Venetoclax Plus Intensive Chemotherapy in AML and Advanced MDS: Assessment of Leukemia Stem Cell Eradication By High-Resolution MRD Assay

P524: PHARMACODYNAMICALLY DEFINED METRONOMIC DOSING OF DECITABINE AND VENETOCLAX IN ACUTE MYELOID LEUKEMIA

P488: SAFETY AND EFFICACY OF VENETOCLAX PLUS “7 + 3” CHEMOTHERAPY IN NEWLY DIAGNOSED AML

Socio-demographic determinants of myelofibrosis outcomes in an underserved center and the SEER national database

Poster: AML-351 Low-Dose Weekly Decitabine and Venetoclax in TP53-Mutated Myeloid Malignancies

AML-351 Low-Dose Weekly Decitabine and Venetoclax in Myeloid Malignancies

ACR Appropriateness Criteria® Acute Pelvic Pain in the Reproductive Age Group: 2023 Update

ALL-040 Hispanic Patients With T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma Had Worse Overall Survival in a Minority Predominant Cohort

Suchergebnisse filtern